Corrigendum to “UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells”

by Yan Wu, Dan Jin, Xiaohong Wang, Jing Du, Weihua Di, Jiajia An, Cuijie Shao, Jiwei Guo
Published 2020-01-01

UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

by Yan Wu, Dan Jin, Xiaohong Wang, Jing Du, Weihua Di, Jiajia An, Cuijie Shao, Jiwei Guo
Published 2019-01-01

Retraction notice to ‘The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC’ [EBioMedicine 37 (2018) 188–204]

by Dan Jin, Jiwei Guo, Deqiang Wang, Yan Wu, Xiaohong Wang, Yong Gao, Cuijie Shao, Xin Xu, Shuying Tan
Published 2021-01-01

The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLCResearch in context

by Dan Jin, Jiwei Guo, Deqiang Wang, Yan Wu, Xiaohong Wang, Yong Gao, Cuijie Shao, Xin Xu, Shuying Tan
Published 2018-11-01